Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

22.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.3K
Gene Therapy00:59

Gene Therapy

4.5K
4.5K
What is Genetic Engineering?00:49

What is Genetic Engineering?

71.0K
Overview
71.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

Delivering the future of immunotherapy: A state-of-the-art review of gene editing in immune cells with lipid nanoparticles.

Materials today. Bio·2026
Same author

Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice.

Molecular therapy. Advances·2026
Same author

Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II.

Frontiers in immunology·2026
Same author

Interindividual variability in immune response to AAV ocular gene delivery across species impedes immunomonitoring.

JCI insight·2026
Same author

Ex vivo long-term expansion of human hematopoietic stem and progenitor cells as a tool for modeling vector integration sites and clonality.

Journal of translational medicine·2026
Same journal

CD4-directed nanoblades enable selective genome editing in CD4<sup>+</sup> cells and HIV suppression in vitro and in vivo.

EMBO molecular medicine·2026
Same journal

Foxs1-mediated transformation of CD34<sup>+</sup> fibroblast to myCAFs promotes tumor growth.

EMBO molecular medicine·2026
Same journal

Patient-derived resources for decoding and targeting brain metastases ecosystems.

EMBO molecular medicine·2026
Same journal

Obeticholic acid alleviates lupus pathology by inhibiting T follicular helper cell differentiation.

EMBO molecular medicine·2026
Same journal

OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation.

EMBO molecular medicine·2026
Same journal

Impaired gephyrin G-domain trimerization and phase separation in a patient with developmental epileptic encephalopathy.

EMBO molecular medicine·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.0K

Gene therapy on the move.

Kerstin B Kaufmann1, Hildegard Büning, Anne Galy

  • 1Institute for Biomedical Research, Georg-Speyer-Haus, Frankfurt, Germany.

EMBO Molecular Medicine
|October 10, 2013
PubMed
Summary
This summary is machine-generated.

Gene therapy has evolved significantly, overcoming early setbacks to become a viable treatment for inherited diseases. Advanced gene transfer tools and gene editing technologies now offer improved safety and efficacy in clinical applications.

Keywords:
clinical trialsiPSmonogenic disordersstem cell therapyviral vectors

More Related Videos

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.1K
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

14.3K

Related Experiment Videos

Last Updated: May 7, 2026

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.0K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.1K
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

14.3K

Area of Science:

  • Medicine
  • Genetics
  • Biotechnology

Background:

  • Gene therapy clinical trials began over 20 years ago.
  • Early trials faced challenges due to severe side effects.
  • Advances in understanding molecular mechanisms have driven progress.

Purpose of the Study:

  • To review the application of gene therapy for inherited diseases.
  • To discuss limitations of early gene therapy trials.
  • To highlight the revival of gene therapy for monogenic disorders.

Main Methods:

  • Development of sophisticated gene transfer tools.
  • Application of advanced gene targeting and editing technologies.
  • Analysis of clinical trial data from over 1900 studies.

Main Results:

  • Recent Phase I/II trials show excellent clinical results with no reported side effects.
  • Gene editing technologies are now applied clinically.
  • Gene therapy has transitioned from experimental to clinical reality.

Conclusions:

  • Gene therapy is a powerful treatment option for monogenic disorders.
  • Improved safety and efficacy characterize modern gene therapy approaches.
  • The field has overcome initial limitations, demonstrating significant therapeutic potential.